PRESS RELEASE published on 01/03/2024 at 17:00, 1 year 11 months ago D'Argenta: Introducing Luxurious Silver and Gold Home Decor Gifts to the USA D'Argenta, a luxury home decor company known for its unparalleled craftsmanship, is set to expand to the United States under the strategic direction of Chief Marketing Officer Simon Abraham. The company offers a range of exquisite silver and gold sculptures, including the majestic Leopard in Silver and a wildlife collection that captures the essence of nature's most majestic creatures. Their home decor line features opulent silver vases, gold-leafed bowls, and intricately designed candelabras. D'Argenta also offers bespoke corporate gift services, exemplifying its fusion of art and corporate prestige. Connoisseurs and corporations are invited to experience the artistry of D'Argenta, where luxury and craftsmanship converge. D'Argenta Luxury Home Decor Silver Sculptures Gold Sculptures Bespoke Corporate Gifts
Published on 12/05/2025 at 02:35, 1 hour 56 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 31 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 26 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 31 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 16 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 21 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 31 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 46 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 47 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 30 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025